MedPath

An experimental study to evaluate the effectiveness of Multi-component Intervention (MCI) on Radiotherapy Induced Fatigue and its correlates among breast cancer patients.

Completed
Conditions
Benign neoplasm of unspecified breast,
Registration Number
CTRI/2022/03/041283
Lead Sponsor
Blessy Mohandass
Brief Summary

This study is a cluster randomized, open label, parallel group, single-centre trial comparing the effectiveness of nurse led multicomponent intervention (MCI) that includes guided imagery, information booklet, weekly messaging reminders for 6 weeks on radiotherapy induced fatigue and its co relates among 100 breast cancer patients receiving radiation therapy that will be conducted in Punjab, India. The primary outcome measures will be Mean Cancer Fatigue Scores, Mean Zung Anxiety Scores, Mean Zung Depression Score, Mean Pittsburg Sleep Quality Index, Mean PG-SGA point Score, Mean Hemoglobin Levels at Four weeks and Six weeks. The secondary outcome will be user satisfaction for MCI at Six weeks.

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Female
Target Recruitment
100
Inclusion Criteria

Female Breast cancer patients who are: above the age of 18 years willing to participate prescribed radiation therapy for at least 6 weeks having smartphone able to read and understand Hindi or English.

Exclusion Criteria

Females Breast cancer patients diagnosed with comorbidities like severe depression, cardiovascular diseases, endocrine diseases, and sleep disorders unable to follow instructions owing to compromised physical and mental health enrolled in another study that involves a similar intervention having compliance less than 75% for MCI.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Mean Fatigue ScoresFour weeks and Six Weeks
Mean nutritional status scoreFour weeks and Six Weeks
Mean Anxiety ScoresFour weeks and Six Weeks
Mean Sleep Quality IndexFour weeks and Six Weeks
Mean Depression ScoreFour weeks and Six Weeks
Secondary Outcome Measures
NameTimeMethod
User Satisfaction for MCISix Weeks

Trial Locations

Locations (1)

Fortis Hospital, Mohali, Punjab

🇮🇳

Patiala, PUNJAB, India

Fortis Hospital, Mohali, Punjab
🇮🇳Patiala, PUNJAB, India
Dr Narendra Kumar Bhalla
Principal investigator
8284011897
narendra.bhalla@fortishealthcare.com

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.